Literature DB >> 7582563

Characterization of receptors for kinins and neurokinins in the arterial and venous mesenteric vasculatures of the guinea-pig.

N Berthiaume1, A Claing, D Regoli, T D Warner, P D'Orléans-Juste.   

Abstract

1. In the present work, we have studied the microvascular reactivity of the arterial and venous mesenteric beds of the guinea-pig to bradykinin, neurokinins and other agents. 2. The vasoactive properties of three selective agonists for neurokinin receptors, namely [Sar9, Met (O2)11]SP (NK1), [beta-Ala8]NKA(4-10) (NK2) and [MePhe7]NKB (NK3), were evaluated on precontracted arterial and venous mesenteric vasculatures of the guinea-pig. The NK1-selective agonist, [Sar9,Met(O2)11]SP (1 to 1000 pmol), induced an endothelium-dependent and N omega-nitro-L-arginine methyl ester (L-NAME)-sensitive relaxation of the arterial vasculature precontracted with methoxamine, whereas the NK2 and NK3-selective agonists were virtually inactive at high doses (1000 pmol). 3. The three selective neurokinin receptor agonists were inactive in the non-precontracted arterial and venous mesenteric vasculatures as well as in the precontracted venous mesenteric vasculature. 4. Bradykinin (0.1 to 100 pmol) induced a marked dose- and endothelium-dependent vasodilatation of the precontracted arterial and venous vasculatures. ED50 values were 5.5 pmol on the arterial side and 1.9 pmol on the venous side. In contrast, desArg9-bradykinin was inactive at doses up to 1000 pmol. Furthermore, on the arterial and venous sides, a higher dose of bradykinin (1000 pmol), induced a biphasic effect, a transient constriction followed by a marked and sustained vasodilatation. The vasodilator effects of bradykinin were abolished by Hoe 140 (0.1 microM) and CHAPS, markedly reduced by L-NAME and were unaffected by [Leu8]desArg9-bradykinin (0.1 microM) on both sides of the mesenteric vasculature. Hoe 140 also abolished the arterial vasoconstrictions induced by high doses of bradykinin. 5. Noradrenaline, angiotensin II and endothelin-1 produced contractions on both sides of the mesenteric circulation, while acetylcholine (arterial side) and sodium nitroprusside (arterial and venous sides) caused vasodilatation.6. Our study supports the view that NK1 receptors responsible for vasodilatation are present solely in the endothelium of the arterial mesenteric vasculature of the guinea-pig. On the other hand, bradykinin(0.1 to 100 pmol) exerts predominantly vasodilator effects on both sides of the mesenteric vasculature via selective activation of B2 receptors located on the endothelium. The same receptor type located on the smooth muscle appears to be responsible for the arterial and venous constriction with high doses of bradykinin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7582563      PMCID: PMC1908793          DOI: 10.1111/j.1476-5381.1995.tb15043.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat.

Authors:  H Kawasaki; K Takasaki; A Saito; K Goto
Journal:  Nature       Date:  1988-09-08       Impact factor: 49.962

2.  Neurokinins produce selective venoconstriction via NK-3 receptors in the rat mesenteric vascular bed.

Authors:  P D'Orléans-Juste; A Claing; S Télémaque; T D Warner; D Regoli
Journal:  Eur J Pharmacol       Date:  1991-11-12       Impact factor: 4.432

3.  Simultaneous perfusion of rat isolated superior mesenteric arterial and venous beds: comparison of their vasoconstrictor and vasodilator responses to agonists.

Authors:  T D Warner
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

4.  The effect of the selective PAF antagonist BN 52021 on PAF- and antigen-induced bronchial hyper-reactivity and eosinophil accumulation.

Authors:  A J Coyle; S C Urwin; C P Page; C Touvay; B Villain; P Braquet
Journal:  Eur J Pharmacol       Date:  1988-03-22       Impact factor: 4.432

5.  Synthesis of bradykinin analogs.

Authors:  G Drapeau; D Regoli
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

Review 6.  Pharmacology of bradykinin and related kinins.

Authors:  D Regoli; J Barabé
Journal:  Pharmacol Rev       Date:  1980-03       Impact factor: 25.468

7.  Structure-activity study of kinins in vascular smooth muscles.

Authors:  P Gaudreau; J Barabé; S St-Pierre; D Regoli
Journal:  Can J Physiol Pharmacol       Date:  1981-04       Impact factor: 2.273

8.  Endothelin-1 and U46619 potentiate selectively the venous responses to nerve stimulation within the perfused superior mesenteric vascular bed of the rat.

Authors:  T D Warner; P D'Orleans-Juste; J R Vane
Journal:  Biochem Biophys Res Commun       Date:  1990-10-30       Impact factor: 3.575

9.  Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit.

Authors:  T D Warner; J A Mitchell; G de Nucci; J R Vane
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

10.  Structure-activity studies of bradykinin and related peptides. B2-receptor antagonists.

Authors:  N E Rhaleb; S Télémaque; N Rouissi; S Dion; D Jukic; G Drapeau; D Regoli
Journal:  Hypertension       Date:  1991-01       Impact factor: 10.190

View more
  2 in total

1.  Mass spectrometry imaging in zebrafish larvae for assessing drug safety and metabolism.

Authors:  Mariana Asslan; Nidia Lauzon; Maja Beus; Dusica Maysinger; Simon Rousseau
Journal:  Anal Bioanal Chem       Date:  2021-06-26       Impact factor: 4.142

Review 2.  The Regulation of Pulmonary Vascular Tone by Neuropeptides and the Implications for Pulmonary Hypertension.

Authors:  Charmaine C W Lo; Seyed M Moosavi; Kristen J Bubb
Journal:  Front Physiol       Date:  2018-08-23       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.